about
Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protectionStructural Basis of Molecular Recognition of the Leishmania Small Hydrophilic Endoplasmic Reticulum-associated Protein (SHERP) at Membrane SurfacesAntileishmanial high-throughput drug screening reveals drug candidates with new scaffoldsLeishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamstersScientists for a better world.Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania.Characterization of a subunit of the outer dynein arm docking complex necessary for correct flagellar assembly in Leishmania donovaniLutzomyia sand fly diversity and rates of infection by Wolbachia and an exotic Leishmania species on Barro Colorado Island, PanamaDETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.Understanding the mechanisms controlling Leishmania amazonensis infection in vitro: the role of LTB4 derived from human neutrophilsEvaluating the accuracy of molecular diagnostic testing for canine visceral leishmaniasis using latent class analysis.Subversion of host cell signalling by the protozoan parasite Leishmania.Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular ApproachesKSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqiCaseating granulomas in cutaneous leishmaniasis.Prevention of canine leishmaniosis in a hyper-endemic area using a combination of 10% imidacloprid/4.5% flumethrin.Detection of Leishmania DNA in wild foxes and associated ticks in Patagonia, Argentina, 2000 km south of its known distribution area.DNA vaccines against tropical parasitic diseases.Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control.Transgenic Leishmania and the immune response to infectionImmunotherapy as a strategy for treatment of leishmaniasis: a review of the literature.Therapy of vector-borne protozoan infections in nonendemic settings.Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems.Intermediate/borderline disseminated cutaneous leishmaniasis.Adenosine and immune imbalance in visceral leishmaniasis: the possible role of ectonucleotidases.Degranulating Neutrophils Promote Leukotriene B4 Production by Infected Macrophages To Kill Leishmania amazonensis Parasites.Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the mitochondrial tryparedoxin peroxidase from Leishmania braziliensisCapillary electrophoresis reveals polyamine metabolism modulation in Leishmania (Leishmania) amazonensis wild type and arginase knockout mutants under arginine starvation.Immunodiagnosis of canine visceral leishmaniasis using mimotope peptides selected from phage displayed combinatorial libraries.Acid-Triggered Degradable Reagents for Differentiation of Adaptive and Innate Immune Responses to Leishmania-Associated Sugars.Using humans to make a human leishmaniasis vaccine.Genetic variation in RPOIILS gene encoding RNA polymerase II largest subunit from Leishmania major.Toxoplasma gondii, Neospora caninum and Leishmania spp. serology and Leishmania spp. PCR in dogs from Pirassununga, SP.Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.Spatio-temporal analysis of cutaneous leishmaniasis using geographic information system among Iranian Army Units and its comparison with the general population of Iran during 2005-2014.Effect of A2 gene on infectivity of the nonpathogenic parasite Leishmania tarentolae.Lesion aspirate culture for the diagnosis and isolation of Leishmania spp. from patients with cutaneous leishmaniasis.
P2860
Q27305883-9CBBD2E5-9BA3-4FB4-8A45-635A500F8AD8Q27666058-C152078E-E142-44EE-A18D-601048BA7D61Q28473835-8DB5428E-7D31-4058-80D7-8AE8F1865346Q28480398-2E4D56AA-0DC4-467F-A1C3-F068BF54F25AQ30399158-0C28DB02-C4A3-426F-8C6A-C67D74B4004EQ33450546-89D01B85-34F0-416B-AB9E-A066F34B6BF5Q33528939-221DD88B-33C1-488F-959F-CC2F8DD487D5Q33541026-6A8E64EB-60FB-4DE5-BDAE-B40324BFD02CQ33784195-89E2C336-03D5-4620-95A4-2E444BFBE5E9Q33953902-81AB7604-4480-4DD2-9522-7DFCB50732C8Q33975650-4DE5F7D1-2AFB-4124-8983-EBFB83C07A13Q33991361-63CE1C04-3DF5-472F-ABB4-4EE7C01591D4Q34076804-CEBF7275-75CF-4536-B83D-AB3DE658498FQ34235741-8E46A6FF-2374-4898-8469-058DBF55A1D7Q34395084-5226F45A-FBE7-43A1-86E0-A741B7E131FFQ34602331-2E0E59B0-2247-490E-B719-5F155DFA77EBQ36002348-FB21167F-C282-46A8-8647-0E93552DB1B6Q36238733-90CE5B8F-61F2-4AB2-8F0C-506C96B412FBQ36539024-9D654E1E-6B8C-4CA0-BDB8-8809FC154EC7Q37081691-349F11B3-9097-4F71-AB42-BF127DDAA2A2Q37773297-19CA9FCE-E114-4404-A719-56CEC0E1C897Q37879203-764B4C54-E406-45A2-A98C-6F8E1C901965Q37965724-CE03986C-6193-423E-9EE0-A03F29DEBA09Q38066602-750EA753-8092-4410-9DE3-B45A087B923FQ38658907-B3E28BBE-8AA8-4DF0-B0F1-EF917FA3A81CQ38800386-26CA77D4-465D-4800-BDB9-17DC77146558Q39507727-8E042723-0468-4752-8017-E625B4AEC2F5Q41094558-1789EE3D-B9E9-4A98-9F5B-62BC4C2B8C39Q41467399-82C7C13E-BFD4-4AF0-828C-66459605663BQ41652146-AE5CBC04-8C91-4A89-AF91-1AA36620B976Q42217105-FCA6D121-B4FA-4415-8481-20BF9B8A20EEQ42231829-44D4032E-28D2-4250-8C81-15C6C73D24D3Q43176199-67FE747A-6EF3-4858-B0E8-246B7135730CQ45412433-F6530D8B-0FA2-4A24-9634-CB7A57B9BF4DQ47224061-8509FA7F-6C0F-40F4-94A3-CA530B4B67DBQ48059220-F9A84FA2-11C0-45FB-9DA9-A7BEC8201C37Q54491617-889B0AFE-2D51-4F59-822C-A30EFFB1B63B
P2860
description
im September 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2004
@uk
name
Focus: Leishmaniasis
@en
Focus: Leishmaniasis
@nl
type
label
Focus: Leishmaniasis
@en
Focus: Leishmaniasis
@nl
prefLabel
Focus: Leishmaniasis
@en
Focus: Leishmaniasis
@nl
P2860
P356
P1476
Focus: Leishmaniasis
@en
P2093
Philippe Desjeux
P2860
P2888
P304
P356
10.1038/NRMICRO981
P407
P577
2004-09-01T00:00:00Z